| editorial | Q871232 |
| scholarly article | Q13442814 |
| P2093 | author name string | L S Chitty | |
| T R Everett | |||
| P2860 | cites work | Update on Procedure-Related Risks for Prenatal Diagnosis Techniques | Q22241937 |
| Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood | Q24657306 | ||
| Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center | Q27007785 | ||
| The clinical significance of blood group antibodies | Q28207801 | ||
| Quantification of Fetal DNA by Use of Methylation-Based DNA Discrimination | Q30987480 | ||
| Noninvasive fetal RhCE genotyping from maternal blood | Q33337785 | ||
| Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma | Q33360224 | ||
| A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma | Q33361680 | ||
| Noninvasive fetal genotyping of human platelet antigen-1a | Q33396206 | ||
| Safe fetal platelet genotyping: new developments | Q33404325 | ||
| New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma. | Q33755108 | ||
| Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. | Q33767643 | ||
| Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study | Q34132783 | ||
| Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience | Q34192088 | ||
| Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA. | Q34200702 | ||
| Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011. | Q34249522 | ||
| RAPIDR: an analysis package for non-invasive prenatal testing of aneuploidy | Q34285347 | ||
| Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma | Q34336915 | ||
| Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. | Q34340985 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| Non-visualisations of the fetal bladder: aetiology and management. | Q34464545 | ||
| Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol | Q34480344 | ||
| The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature | Q34853775 | ||
| Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women | Q34853996 | ||
| Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing | Q35032051 | ||
| Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis | Q35209735 | ||
| Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age. | Q35447245 | ||
| Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
| Digital PCR for the molecular detection of fetal chromosomal aneuploidy | Q35916813 | ||
| Non-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users' perspective | Q36333978 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Chromosomal microarray versus karyotyping for prenatal diagnosis | Q36546668 | ||
| Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma | Q36595101 | ||
| Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma | Q37000915 | ||
| Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples | Q37004989 | ||
| Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis | Q37059519 | ||
| Next generation sequencing of SNPs for non-invasive prenatal diagnosis: challenges and feasibility as illustrated by an application to β-thalassaemia. | Q37316945 | ||
| Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects | Q37351817 | ||
| Early prenatal diagnosis of skeletal anomalies | Q37826401 | ||
| Prenatal management of disorders of sex development | Q38058186 | ||
| The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made | Q38099617 | ||
| Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies | Q38101277 | ||
| Non-invasive prenatal testing for aneuploidy: current status and future prospects | Q38114375 | ||
| Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature | Q38125160 | ||
| Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care | Q38178923 | ||
| Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. | Q38186934 | ||
| Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review | Q38213813 | ||
| ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. | Q38217481 | ||
| Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia | Q40028010 | ||
| Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service | Q40626763 | ||
| Costs and benefits of non-invasive fetal RhD determination | Q43448023 | ||
| Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. | Q43981389 | ||
| Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease | Q44602113 | ||
| New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011). | Q44637363 | ||
| Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood | Q44645735 | ||
| Non-invasive prenatal determination of fetal sex: translating research into clinical practice | Q44982893 | ||
| A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing | Q45049473 | ||
| Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis | Q46172895 | ||
| Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. | Q51163080 | ||
| Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. | Q51349861 | ||
| Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake. | Q51461502 | ||
| Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. | Q51767524 | ||
| Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. | Q51836356 | ||
| Discordant results between fetal karyotyping and non-invasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. | Q54266541 | ||
| Non-invasive prenatal diagnosis for single gene disorders: experience of patients | Q56266931 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital | Q57177380 | ||
| Noninvasive prenatal testing for aneuploidy–ready for prime time? | Q57839590 | ||
| Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service | Q58028956 | ||
| Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics | Q61847812 | ||
| Counseling for non-invasive prenatal testing (NIPT): what pregnant women may want to know | Q61852117 | ||
| Placental volume measured by three-dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects | Q81816985 | ||
| Anti-RhD prophylaxis for RhD negative pregnant women | Q85253094 | ||
| Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy | Q85495453 | ||
| Maternal plasma cell-free DNA in the prediction of pre-eclampsia | Q85633853 | ||
| Cell-free fetal DNA sex determination identified a maternal SRY gene with a known X chromosome deletion | Q86533273 | ||
| European non-invasive trisomy evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing | Q86994177 | ||
| Non-invasive prenatal testing for trisomy 13: more harm than good? | Q87726122 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 499-507 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | Ultrasound in Obstetrics and Gynecology | Q1817048 |
| P1476 | title | Cell-free fetal DNA: the new tool in fetal medicine | |
| P478 | volume | 45 |
| Q50142690 | Comments on Editorial: Has Noninvasive Prenatal Testing (NIPT) Come of Age? |
| Q98475414 | Evaluation of Beta -Thalassemia in the Fetus through cffDNA with Multiple Polymorphisms as a Haplotype in the Beta-Globin Gene |
| Q39278884 | Lost in Translation? Ethical Challenges of Implementing a New Diagnostic Procedure |
| Q38659564 | Opening Pandora's box?: ethical issues in prenatal whole genome and exome sequencing |
| Q39431976 | Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities. |
| Q42917530 | Three-hour analysis of non-invasive foetal sex determination: application of Plexor chemistry |
Search more.